Researchers find new target for Alzheimer's drug development
Researchers at the University of Minnesota's Center for Drug Design have developed a synthetic compound that, in a mouse model, successfully prevents the neurodegeneration associated with Alzheimer's disease.
Alzheimer's disease & dementia
Dec 03, 2012 |
5 / 5 (1) |
0
|
US meningitis death toll rises to 30, officials say
The death toll from a meningitis outbreak linked to tainted drugs rose to 30 as the number of cases climbed to a whopping 419, US health officials said Monday.
Diseases, Conditions, Syndromes
Nov 05, 2012 |
not rated yet |
0
US firm loses license as tainted drug toll rises to 24
US officials revoked the license Wednesday of a Massachusetts pharmacy cited for significant sanitary violations as the toll from a meningitis outbreak tied to its tainted drugs rose to 24.
Diseases, Conditions, Syndromes
Oct 25, 2012 |
not rated yet |
0
US meningitis death toll up to 23: CDC
The death toll in the United States from an unprecedented outbreak of fungal meningitis linked to a contaminated drug has climbed to 23 people, health officials said Saturday.
Diseases, Conditions, Syndromes
Oct 20, 2012 |
5 / 5 (1) |
0
Illegal drug users more likely to use new synthetic drugs and pharmaceuticals
(Medical Xpress)—Methamphetamine users' use of synthetic cannabis products (such as Kronic) increased from ten per cent in 2010 to 41 per cent in 2011 an annual report on illegal drug use shows. Many of these synthetic ...
Addiction
Oct 18, 2012 |
not rated yet |
0
New malaria drug requires just one dose and appears twice as effective as existing regimen
Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective as the best current medicine against this global scourge and may fight off the disease with ...
Diseases, Conditions, Syndromes
Oct 17, 2012 |
not rated yet |
0
US meningitis outbreak death toll rises to 15
The death toll from an unprecedented US meningitis outbreak tied to a tainted steroid jumped to 15 after another person died from a fungal form of the disease, health authorities said Saturday.
Diseases, Conditions, Syndromes
Oct 14, 2012 |
not rated yet |
0
US tainted drug outbreak rises to 185 cases
The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.
Diseases, Conditions, Syndromes
Oct 12, 2012 |
not rated yet |
0
Calls for more US oversight after tainted drug outbreak
A deadly meningitis outbreak in the United States blamed on a tainted drug has triggered outrage and calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.
Medications
Oct 11, 2012 |
not rated yet |
0
Tainted drug death toll rises to 14 in US
The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.
Diseases, Conditions, Syndromes
Oct 11, 2012 |
not rated yet |
0
New research looks to reduce animal testing for drug development
Researchers from Royal Holloway, University of London are looking at ways of testing the side effects of new drugs without using animals.
Medical research
Oct 10, 2012 |
5 / 5 (1) |
0
New evidence on easing inflammation of brain cells for Alzheimer's disease
New research proves the validity of one of the most promising approaches for combating Alzheimer's disease (AD) with medicines that treat not just some of the symptoms, but actually stop or prevent the disease ...
Alzheimer's disease & dementia
Oct 03, 2012 |
5 / 5 (1) |
0
New type of drug leads to hope against resistant ovarian cancer
Scientists at USC have discovered a new type of drug for the treatment of ovarian cancer that works in a way that should not only decrease the number of doses that patients need to take, but also may make it effective for ...
Cancer
Oct 03, 2012 |
not rated yet |
0
|
Scientists reverse Alzheimer's-like memory loss in animal models by blocking EGFR signaling
A team of neuroscientists and chemists from the U.S. and China today publish research suggesting that a class of currently used anti-cancer drugs as well as several previously untested synthetic compounds show effectiveness ...
Alzheimer's disease & dementia
Sep 24, 2012 |
4.8 / 5 (4) |
0
|
Previously undiscovered cannibis compound could lead to improved epilepsy treatment
(Medical Xpress)—Scientists at the University of Reading have demonstrated for the first time that a previously unstudied chemical in cannabis could lead to more effective treatments for people with epilepsy.
Neuroscience
Sep 13, 2012 |
5 / 5 (3) |
1
|
